SEC Form 4 · accession 0001125345-17-000083
MACROGENICS INC · MGNX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Jon Marc Wigginton
Officer — Sr VP, Clinical Dev. & CMO
Period of report
Jun 5, 2017
Accepted (ET)
Jun 6, 2017 · 4:04 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001125345
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jun 5, 2017 | M | 5,000 | $4.70 | A | 35,000 | D | |
| Common StockF1,F2,F3 | Jun 5, 2017 | S | 5,000 | $20.00 | D | 30,000 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee stock option (right to buy) | $4.70 | Jun 5, 2017 | M | 5,000 | D | Jan 18, 2014 | Jul 18, 2023 | Common Stock | 5,000 | 65,448 | D |
Explanation of responses
- F1The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 15, 2016.
- F2This transaction was executed in multiple trades at prices ranging from $20 to $20.02.
- F3This amount includes 30,000 Restricted Stock Units (RSU) acquired on 2/25/16 which will vest on 2/25/18.